UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 5, 2013

 

 

Vitamin Shoppe, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-34507   11-3664322

(State or Other Jurisdiction of

Incorporation or Organization)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

2101 91st Street

North Bergen, New Jersey 07047

(Addresses of Principal Executive Offices, including Zip Code)

(201) 868-5959

(Registrant’s Telephone Number, Including Area Code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


ITEM 5.07 Submission of Matters to a Vote of Security Holders.

On June 5, 2013, the Vitamin Shoppe, Inc. (“the Company”) held its Annual Meeting of Stockholders (“the Annual Meeting”). At the Annual Meeting, our stockholders: (a) elected the persons listed below to serve as directors for a term of one year expiring at the 2014 Annual Meeting or until their successors are duly elected and qualified; (b) approved the compensation paid to the Company’s named executive officers; and (c) ratified the appointment of Deloitte & Touche LLP to serve as the Company’s independent registered public accounting firm for the 2013 fiscal year. Set forth below are the voting results for each of these proposals:

 

a. All of the director nominees were elected to serve until the Annual Meeting in 2014 or until their respective successors are duly elected and qualified.

 

Director

  

For

    

Against

    

Abstain

    

Non-Votes

 

B. Michael Becker

     28,110,624         326,393         19,756         487,107   

Catherine Buggeln

     28,128,807         326,907         1,059         487,107   

Deborah M. Derby

     28,387,943         67,771         1,059         487,107   

John H. Edmondson

     28,110,879         326,582         19,312         487,107   

David H. Edwab

     28,110,899         326,662         19,212         487,107   

Richard L. Markee

     27,576,128         860,833         19,812         487,107   

Richard L. Perkal

     28,417,738         19,893         19,142         487,107   

Beth M. Pritchard

     28,336,864         118,550         1,359         487,107   

Katherine Savitt

     28,386,526         69,188         1,059         487,107   

Anthony N. Truesdale

     28,412,222         24,809         19,742         487,107   

 

b. An advisory (non-binding) vote approved the executive compensation of our named executive officers.

 

For

  

Against

  

Abstain

  

Non-Votes

28,311,840    123,672    21,261    487,107

 

c. The proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the 2013 fiscal year was approved.

 

For

  

Against

  

Abstain

  

Non-Votes

26,953,624    1,989,088    1,168   

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

        Vitamin Shoppe, Inc.
Date: June 7, 2013     By:  

/s/ Jean Frydman

    Name:   Jean Frydman
    Title:   Senior Vice President, General Counsel and Corporate Secretary